Volume 24, Number 3—March 2018
Research
Emergence of Streptococcus pneumoniae Serotype 12F after Sequential Introduction of 7- and 13-Valent Vaccines, Israel
Assaf Rokney
, Shalom Ben-Shimol, Zinaida Korenman, Nurith Porat, Zeev Gorodnitzky, Noga Givon-Lavi, Merav Ron, Vered Agmon, Ron Dagan, and Lea Valinsky
, Shalom Ben-Shimol, Zinaida Korenman, Nurith Porat, Zeev Gorodnitzky, Noga Givon-Lavi, Merav Ron, Vered Agmon, Ron Dagan, and Lea Valinsky
Table 1
Age distribution of case-patients with of Sp12F infection, Israel, July 2009–June 2016*
| Year |
Age <5 y |
Age 5–17 y |
Age 17–64 y |
Age >65 y |
|||||||
| No. cases |
Total population |
No. cases |
Total population |
No. cases |
Total population |
No. cases |
Total population |
||||
| Jul 2009–Jun 2010 | 11 | 763,700 | 1 | 1,706,200 | 3 | 4,341,250 | 5 | 743,250 | |||
| Jul 2010–Jun 2011 | 17 | 784,000 | 2 | 1,737,250 | 13 | 4,405,100 | 9 | 768,100 | |||
| Jul 2011–Jun 2012 | 38 | 804,750 | 1 | 1,768,700 | 16 | 4,465,500 | 14 | 799,000 | |||
| Jul 2012–Jun 2013 | 36 | 824,300 | 2 | 1,802,100 | 17 | 4,526,750 | 13 | 831,750 | |||
| Jul 2013–Jun 2014 | 48 | 841,400 | 2 | 1,841,100 | 15 | 4,589,000 | 12 | 866,050 | |||
| Jul 2014–Jun 2015 | 34 | 864,000 | 4 | 1,904,700 | 32 | 4,692,000 | 18 | 919,600 | |||
| Jul 2015–Jun 2016 |
42 |
885,600 |
2 |
1,947,100 |
13 |
4,765,500 |
14 |
959,650 |
|||
| Total no. cases | 226 | 14 | 109 | 85 | |||||||
*Sp12F, Streptococcus pneumoniae serotype 12F.
Page created: February 15, 2018
Page updated: February 15, 2018
Page reviewed: February 15, 2018
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
Content Credential